1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Metagenomics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Metagenomics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Metagenomics Market Regional Analysis
6.2 Asia Pacific Metagenomics Market Revenue 2016-2027 (US$ Million)
6.3 Asia Pacific Metagenomics Market Forecast Analysis
7. Asia Pacific Metagenomics Market Analysis – by Product
7.1 Instruments & Software and Consumables
- 7.1.1 Overview
- 7.1.2 Instruments & Software and Consumables: Asia Pacific Metagenomics Market – Revenue and Forecast, 2016-2027 (US$ Million)
8. Asia Pacific Metagenomics Market Analysis – by Application
8.1 Clinical Diagnostics
- 8.1.1 Overview
- 8.1.2 Clinical Diagnostics: Asia Pacific Metagenomics Market – Revenue and Forecast, 2016-2027 (US$ Million)
8.2 Drug Discovery Metagenomics
- 8.2.1 Overview
- 8.2.2 Drug Discovery Metagenomics: Asia Pacific Metagenomics Market – Revenue and Forecast, 2016-2027 (US$ Million)
9. Asia Pacific Metagenomics Market – Asia-Pacific Analysis
9.1 Overview
9.2 Asia-Pacific
- 9.2.1 Asia Pacific Metagenomics Market Breakdown, by Key
Country, 2019 and 2027 (%)
- 9.2.1.1 Asia Pacific Metagenomics Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 China:
Asia Pacific Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.1.1 China: Asia Pacific Metagenomics Market Breakdown, by Product
- 9.2.1.1.2 China: Asia Pacific Metagenomics Market Breakdown, by Application
- 9.2.1.2 India:
Asia Pacific Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.2.1 India: Asia Pacific Metagenomics Market Breakdown, by Product
- 9.2.1.2.2 India: Asia Pacific Metagenomics Market Breakdown, by Application
- 9.2.1.3 Japan:
Asia Pacific Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.3.1 Japan: Asia Pacific Metagenomics Market Breakdown, by Product
- 9.2.1.3.2 Japan: Asia Pacific Metagenomics Market Breakdown, by Application
- 9.2.1.4 Australia:
Asia Pacific Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.4.1 Australia: Asia Pacific Metagenomics Market Breakdown, by Product
- 9.2.1.4.2 Australia: Asia Pacific Metagenomics Market Breakdown, by Application
- 9.2.1.5 Rest of Asia-Pacific :
Asia Pacific Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Metagenomics Market Breakdown, by Product
- 9.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Metagenomics Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Merck KGaA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Thermo Fisher Scientific Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Agilent Technologies
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Qiagen
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Bio-Rad Laboratories, Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Perkinelmer Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Illumina Inc.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 F Hoffman-La Roche Ltd.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Oxford Nanopore Technologies Ltd.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Pacific Bioscience of California, Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations